Loading…
UiPath, Inc.
NYSE: PATH Technology IT 🔎 Screen
🏹 Trader: 🚀 Stage 2 + Near High 📈 Stage 2 🎯 Near 52W High View all →
📈 Stage 2 detected Find the fundamental catalyst → → run Growth Triggers in Ask AI
$8.8B
Market Cap
24.2
P/E
0.64
PEG
32.8%
ROCE
14.4%
ROE
0.03
D/E
3.5%
OPM
-14.1%
% from 52W High
89
α RS
🔍 PATH is showing a high-conviction setup because it matches 6 of 37 tracked screener presets, RS Rating is 89, and an ECS of 58.5 last quarter. Net: Broad signal stack, not a recommendation. ? Conviction RS Rating ECS
Sources
Conviction 6/37 · RS Rating 89 · ECS 58.5
⚖️ Compare 🔒 Generate Report 🔒 Research Packet 📚 Guides
🌏 Global Investor Returns
Currency-adjusted total returns for PATH including FX impact
🌏
Click 🌏 Returns tab to load data
📈 Price History
Ratio Health
Excellent
Good
Average
Poor
By Category
📊 Sector Averages
About

UiPath, Inc. provides an automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally.

Key Ratios Snapshot
📈 Growth Pattern
📊 Quick Scorecard
Loading…
⭐ Superinvestors Holding PATH
View All Superinvestors →
Manager Shares Value % of Fund Period
Steve Cohen Point72 Asset Management 1.95M $21.6M 0.03% Mar 2026

SEC Form 13F data. 45-day lag from quarter end.

🔒
Premium Feature
AI-generated 10-section company profile — business model, financials, strengths, risks & management quality
Upgrade to Premium
Already a member? Log in
📐
3-Statement Financial Model
Bear / Base / Bull projections · DCF fair value · Reverse-DCF
Open Model →
🎙 Management Tone Confident Specific → Stable 4 quarters Full tone analysis in Intelligence →
📊 MIXED Strong Q1 with $418M revenue (+17% YoY), ARR $1.901B (12% growth), first GAAP profitable Q1.
Revenue & Profitability
Q1 FY2027 revenue was $418M, up 17% YoY (15% constant currency). ARR reached $1.901B, up 12% YoY (11% constant currency), with net new ARR of $49M. Non-GAAP operating income was $92M (22% margin), and GAAP operating income was $28M (first GAAP-profitable Q1). Non-GAAP adjusted free cash flow was $130M. Dollar-based gross retention was 97%, and net dollar retention was 109% (108% constant currency). Guidance: Q2 FY2027 revenue $395M-$400M, ARR $1.929B-$1.934B; full-year FY2027 revenue $1.776B-$1.781B, ARR $2.058B-$2.063B, non-GAAP operating income ~$430M.
Outlook
Management described the demand environment as 'relatively stable' versus prior quarters, with healthy pipeline and conversion rates. They noted a 'variable macroeconomic environment' but consider it a 'new normal.' FX headwinds from INR and Romanian leu are expected to be nominal. Customer focus is shifting from point AI agents to end-to-end process orchestration, which management believes positions UiPath favorably for the next phase of enterprise AI adoption.
Growth Drivers
Key growth levers include AI adoption (present in 16 of top 20 deals, with AI-inclusive expansion deals 6x larger), vertical solutions (healthcare, financial services, CFO office), and process orchestration products (Maestro and Maestro Case). The coding agents launch aims to compress deployment timelines from weeks to hours, reducing automation backlog. The partner ecosystem (Deloitte embedding Test Cloud, Accenture scaling deployments) and forward deployed engineer program also drive expansion. Customer cohort growth: $100k+ ARR customers up 11% to 2,624, $1M+ ARR up 18% to 374.
Balance Sheet & CapEx
Not discussed in this earnings call. No specific CapEx guidance or infrastructure investment details were provided.
Margins
Non-GAAP operating margin was 22% in Q1 FY2027, up over 250 basis points year-over-year. Full-year FY2027 non-GAAP operating income guidance of ~$430M implies an approximate 24% margin on expected revenue. Gross margin was 83% overall (90% software), with FY2027 gross margin guidance of ~84%. Management noted a 'invest first, waste nothing' mindset, leveraging AI internally to drive efficiency while investing in R&D, vertical solutions, and customer-facing functions. They previously updated the long-term non-GAAP operating margin target to 30%.
Key Risks
Risks flagged include: variable macroeconomic environment impacting deal timing and budgets, foreign exchange volatility (INR, Romanian leu), concentration of customer attrition among the smallest customers (while larger customers grow), and the need to sustain AI adoption and vertical solution momentum. Management also noted the 'automation backlog' and maintenance costs as persistent challenges that coding agents aim to address. Analysts probed the sustainability of revenue outpacing ARR growth, but management attributed it to 606 timing and services mix.
Generated by AI · Q1 2027 results · Not investment advice
🔒
Free Account Required

Create a free Finmagine account to access Finmagine™ Scorecard.

See how this company scores across 5 dimensions — Financial Health, Growth Prospects, Competitive Position, Management Quality, and Valuation — powered by 30+ computed ratios.

Create Free AccountLog In
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Ask AI.

Get 25 expert AI analysis templates — Business KPIs, Comprehensive, Forensic Governance, Peer Comparison, Risk-Reward, Full Research Report, IPO Decoder, Red Flag Detector, and more — ready to paste into ChatGPT, Claude, Gemini, or Perplexity.

Upgrade to PremiumCreate Free Account
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Peer Comparison.

Compare this company side-by-side against its sector peers with financial metrics, ratio benchmarking, and relative performance across all key dimensions.

Upgrade to PremiumCreate Free Account
✓ 📞 Earnings Call Transcripts (5 quarters) submit a missing quarter
🔍
🔎 See cross-company document search → ?
📞 Earnings Call Transcripts (5)
Q1 2027 Q1 2027 2026-05-28
Q1 FY2027 exceeded guidance with 17% revenue growth, first-ever GAAP profitability, and strong AI-driven enterprise adoption. Large deals increasingly include AI and process orchestration, with robust retention and expanding vertical solutions.
Q4 2026 Q4 2026 2026-03-11
Delivered record Q4 and FY26 results with first-ever GAAP profitability, strong AI-driven growth, and robust cloud ARR. FY27 guidance reflects continued expansion, margin improvement, and disciplined capital allocation amid variable macro conditions.
Q3 2026 Q3 2026 2025-12-03
Revenue grew 16% year-over-year to $411M, with ARR up 11% to $1.782B and first GAAP profitable Q3. Strong customer expansion, high retention, and new platform innovations drove results. Q4 guidance raised despite FX headwinds, with no material agentic AI revenue expected in FY26.
Q2 2026 Q2 2026 2025-09-04
Q2 FY26 results exceeded guidance, with 14% revenue growth and strong adoption of agentic automation solutions. Cloud ARR rose over 25%, and public sector, financial services, and healthcare showed notable strength. FY26 guidance was raised, reflecting continued operational efficiency and prudent outlook.
Q1 2026 Q1 2026 2025-05-29
Q1 revenue grew 6% to $357M and ARR rose 12% to $1.693B, with strong non-GAAP margins and cash flow. Agentic automation platform launch drove customer wins and industry recognition, while FY26 is positioned as a foundational year for future growth. Fiscal guidance remains prudent amid macro uncertainty.
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Catalyst Timeline.

Every result, order win, insider trade, ECS update, earnings-call, and SEC announcement for this company — in one chronological lane.

Upgrade to PremiumCreate Free Account
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Full Report.

Read the complete Finmagine™ investment research report — comprehensive fundamental analysis, business model assessment, competitive positioning, and investment recommendation.

Upgrade to PremiumCreate Free Account

📊 Analysis Methodology

This comprehensive investment analysis was conducted using The Finmagine™ Stock Analysis & Ranking Methodology, a proprietary framework that systematically evaluates stocks across five critical dimensions: Financial Health, Growth Prospects, Competitive Positioning, Management Quality, and Valuation.

🎯
Discover Our Proven Investment Framework Learn how we analyze and rank stocks using advanced quantitative models, multi-dimensional scoring systems, and dynamic discriminatory ranking techniques that have guided successful investment decisions across market cycles.
📊 Explore The Finmagine™ Methodology

A comprehensive, bias-free framework for analyzing and ranking stocks by Financial Strength, Growth Potential, Competitive Edge, Management Quality, and Value.

Financial Model
Projections are built from each company's audited annual financials (Income Statement, Balance Sheet, Cash Flow) over the last 5 fiscal years. Forward assumptions — revenue growth %, EBITDA margin, D&A (USD millions), interest expense, tax rate, and capex — are AI-generated using historical context and refreshed twice a year: after the December results season and after the September/Q4 results season.

DCF Valuation
Fair Value = Σ(FCFt / (1+WACC)t) + Terminal Value. Terminal Value uses the Gordon Growth Model: FCF5 × (1+g) / (WACC−g). Default WACC: 10% (US risk-free ~4.5%, equity risk premium ~5.5%). Default terminal growth: 3% (long-run US nominal GDP proxy).

CAGR Tracker
Expected 5-year CAGR = (DCF Fair Value / Current Price)1/5 − 1. Assumes fair value is reached in exactly 5 years — a mechanical estimate only.

Data Sources & Limitations
Financial statements sourced from public filings. Prices updated daily. Forward assumptions are AI-generated. All monetary values in USD millions. Non-US ADR companies may have currency conversion inaccuracies. Models are point-in-time and do not update intra-quarter or account for M&A, macro shocks, or extraordinary items.

⚠️ Important Disclaimers — Please read without fail.

Investment Risk:
Investing in securities, including US equities and ETFs, involves inherent risks including the potential loss of principal. All investments are subject to market fluctuations, economic conditions, regulatory changes, and other factors that may affect their value. Past performance is not indicative of future results. This analysis is provided for informational and educational purposes only and should not be construed as investment advice under any circumstances.

No Investment Recommendation:
This analysis does not constitute, nor should it be interpreted as, an offer, solicitation, or recommendation to buy, sell, or hold any securities or financial products. Investors are strongly advised to conduct their own independent research and due diligence and to consult with a licensed financial advisor or an SEC-registered investment adviser before making any investment decisions, taking into account their individual financial situation, risk tolerance, and investment objectives.

Not SEC-Registered:
Finmagine is not registered as an investment adviser with the U.S. Securities and Exchange Commission (SEC) or any state securities authority. Nothing on this platform constitutes investment advice as defined under the Investment Advisers Act of 1940.

Conflict of Interest Disclosure:
The author and/or analyst may currently hold or have previously held positions in the securities discussed. Any such positions are not intended to influence the objectivity or independence of the analysis. This research is produced independently and is not sponsored, endorsed, or commissioned by any company or institution.

Information Sources:
The analysis is based on publicly available information including SEC filings (10-K, 10-Q), annual reports, management commentary, and publicly available financial data. Information is believed to be accurate as of the date of publication but may be subject to change without notice. Readers are encouraged to independently verify all information before acting upon it.

Forward-Looking Statements:
This analysis may contain forward-looking statements, forecasts, or projections that are inherently subject to risks, uncertainties, and assumptions. Actual results may differ materially from those expressed or implied. Finmagine does not undertake any obligation to update such statements in the future.

Limitation of Liability:
The content is provided "as is" without any warranties, express or implied. Finmagine expressly disclaims any liability for errors, omissions, or any losses incurred as a result of reliance on the information provided. Readers assume full responsibility for their investment decisions.